Skip to main navigation

EyePoint Pharmaceuticals

share and print menu

Quarterly Results

Show all

2020

Second Quarter

EyePoint Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Corporate Developments
EyePoint Second Quarter 2020 Financial Results Conference Call

Fiscal First Quarter

EyePoint Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Developments
EyePoint First Quarter 2020 Financial Results Conference Call

2019

Fourth Quarter

EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Corporate Progress
Fourth Quarter and Full Year 2019 Financial Results Conference Call

Third Quarter

EyePoint Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Progress
EyePoint Pharmaceuticals Third Quarter 2019 Earnings Conference Call

Second Quarter

EyePoint Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
EyePoint Pharmaceuticals Second Quarter 2019 Earnings Conference Call

First Quarter

EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress
EyePoint Pharmaceuticals First Quarter 2019 Earnings Conference Call

Three and Six-Month Fiscal Period Ended December 31, 2018

EyePoint Pharmaceuticals Reports Fiscal Period Ended December 31, 2018 Financial Results and Highlights Recent Clinical and Operational Developments
Fiscal Period Ended December 31, 2018 Financial Results Conference Call

Fiscal First Quarter

EyePoint Pharmaceuticals Reports Fiscal First Quarter 2019 Financial Results and Highlights Recent Clinical and Operational Developments
Q1 2019 EyePoint Pharmaceuticals Earnings Conference Call

2018

Fourth Quarter

EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress

Third Quarter

EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results

Second Quarter

pSivida Corp. Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines

First Quarter

pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution

2017

Fourth Quarter

pSivida Corp. Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results

Third Quarter

pSivida Corp. Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track

Second Quarter

pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results

First Quarter

pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives &amp; Milestone Timeline

2016

Fourth Quarter

pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2016 Results

Third Quarter

pSivida Corp. Provides Company Update and Reports Third Quarter FY 2016 Results

Second Quarter

pSivida Corp. Provides Company Update and Reports Second Quarter FY 2016 Results

First Quarter

pSivida Corp. Provides Company Update and Reports First Quarter FY 2016 Results

2015

Fourth Quarter

pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2015 Results

Third Quarter

pSivida Corp. Reports Third Quarter FY 2015 Results

Second Quarter

pSivida Corp. Reports Second Quarter FY 2015 Results

First Quarter

pSivida Corp. Reports First Quarter FY 2015 Results

2014

Fourth Quarter

pSivida Corp. Reports Fourth Quarter and FY 2014 Results
Form 10-K

Third Quarter

pSivida Corp. Reports Third Quarter 2014 Results
Form 10-Q

Second Quarter

pSivida Corp. Reports Second Quarter 2014 Results
Form 10-Q

First Quarter

Form 10-Q
pSivida Corp. Reports First Quarter 2014 Results

2013

Fourth Quarter

pSivida Corp. Reports Fourth Quarter and Fiscal Year 2013 Results

Third Quarter

pSivida Corp. Reports Third Quarter Fiscal Year 2013 Results

Second Quarter

pSivida Corp. Reports Second Quarter Fiscal Year 2013 Results

First Quarter

pSivida Corp. Reports First Quarter Fiscal Year 2013 Results

2012

Fourth Quarter

pSivida Corp. Reports Fourth Quarter and Fiscal Year 2012 Results

Third Quarter

pSivida Corp. Reports Results for the Third Quarter Ended March 31, 2012

Second Quarter

pSivida Corp. Reports Results for the Second Quarter Ended December 31, 2011

First Quarter

pSivida Corp. Reports Results for the First Quarter Ended September 30, 2011

2011

Fourth Quarter

pSivida Corp. Reports Fourth Quarter and Fiscal Year 2011 Results

Third Quarter

pSivida Corp. Reports Results for the Third Quarter Ended March 31, 2011

Second Quarter

pSivida Corp. Reports Results for the Second Quarter Ended December 31, 2010

First Quarter

pSivida Corp. Reports Results for the First Quarter Ended September 30, 2010

2010

Fourth Quarter

pSivida Corp. Reports Fourth Quarter and Fiscal Year 2010Financial Results

Third Quarter

pSivida Corp. Reports Third Quarter Fiscal Year 2010Financial Results

Second Quarter

pSivida Corp. Reports Results for the Second Quarter Ended December 31, 2009

First Quarter

pSivida Corp. Reports Results for the First Quarter Ended September 30, 2009

2009

Fourth Quarter

pSivida Corp. Reports Results for the Fourth Quarter and Fiscal Year Ended June 30, 2009

Third Quarter

pSivida Corp. Reports Results for the Quarter ended March 31, 2009

Second Quarter

pSivida Corp. Reports Results for the Second Quarter Ended December 31, 2008 219.2 KB

First Quarter

pSivida Corp. Reports Results for the First Quarter Ended September 30, 2008 209 KB

2008

Fourth Quarter

2008 Form 10-K 979.1 KB

Shareholder Tools

Printed Materials
Email Alerts
RSS News Feeds

Search Investor Relations

Share this on:
Delicious
Digg
Facebook
LinkedIn
Twitter

© EyePoint Pharmaceuticals 2020

Phone: 1-833-EyePoint (1-833-393-7646) | Fax: 617-926-5050 US | WEB SITE TERMS AND CONDITIONS

info@eyepointpharma.com

About
Products & Technology
News & Events
Investors
Patient Advocacy
Careers

About |
Products & Technology |
News & Events |
Investors |
Patient Advocacy |
Careers

Main navigation

Financial Information
Resources
Corporate Governance
FAQs
ASX Delisting

Sitemap
IR Contacts

EyePoint Pharmaceuticals